Literature DB >> 20717123

Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients.

Konstantinos Stellos1, Victoria Panagiota, Andreas Kögel, Thomas Leyhe, Meinrad Gawaz, Christoph Laske.   

Abstract

Vascular risk factors contribute to the progression of dementia in Alzheimer's disease (AD) and influence platelet activation. However, the degree of platelet activation as a possible underlying mechanism of this progression has not been studied till now. Significantly higher baseline expression of both platelet activation biomarkers, activated glycoprotein IIb-IIIa complex and P-selectin, was observed in patients with AD with fast cognitive decline compared with AD patients with slow cognitive decline during a 1-year follow-up period. These results suggest that platelet activation could be a putative prognostic biomarker for the rate of cognitive decline and a potential new treatment target in AD patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717123      PMCID: PMC3023934          DOI: 10.1038/jcbfm.2010.140

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  16 in total

1.  Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication.

Authors:  K Stellos; B Bigalke; D Stakos; N Henkelmann; M Gawaz
Journal:  J Thromb Haemost       Date:  2009-10-23       Impact factor: 5.824

2.  Platelet APP isoform ratios correlate with declining cognition in AD.

Authors:  F Baskin; R N Rosenberg; L Iyer; L Hynan; C M Cullum
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

3.  Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. Role of serotonin, thromboxane A2, and adenine nucleotides.

Authors:  D S Houston; J T Shepherd; P M Vanhoutte
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

4.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.

Authors:  Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger
Journal:  Arch Intern Med       Date:  2002-10-14

5.  Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  C M Clark; L Sheppard; G G Fillenbaum; D Galasko; J C Morris; E Koss; R Mohs; A Heyman
Journal:  Arch Neurol       Date:  1999-07

6.  Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community.

Authors:  Laure Carcaillon; Karine Pérès; Jean-Jacques Péré; Catherine Helmer; Jean-Marc Orgogozo; Jean-François Dartigues
Journal:  Dement Geriatr Cogn Disord       Date:  2007-04-26       Impact factor: 2.959

7.  Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings.

Authors:  T K Tatemichi; M A Foulkes; J P Mohr; J R Hewitt; D B Hier; T R Price; P A Wolf
Journal:  Stroke       Date:  1990-06       Impact factor: 7.914

8.  Treatment of a whole population sample of Alzheimer's disease with donepezil over a 4-year period: lessons learned.

Authors:  Sarah Lyle; Moni Grizzell; Sasi Willmott; Susan Benbow; Michael Clark; David Jolley
Journal:  Dement Geriatr Cogn Disord       Date:  2008-01-30       Impact factor: 2.959

9.  Rate of progression in Alzheimer's disease correlates with coated-platelet levels--a longitudinal study.

Authors:  Calin I Prodan; Elliott D Ross; Andrea S Vincent; George L Dale
Journal:  Transl Res       Date:  2008-08-09       Impact factor: 7.012

10.  Hyperresponsiveness of platelets in ischemic stroke.

Authors:  Suzanne Fateh-Moghadam; Patrik Htun; Bernd Tomandl; Dirk Sander; Konstantinos Stellos; Tobias Geisler; Harald Langer; Kodwo Walton; Rene Handschu; Christoph Garlichs; Werner G Daniel; Meinrad Gawaz
Journal:  Thromb Haemost       Date:  2007-06       Impact factor: 5.249

View more
  27 in total

1.  Platelet decline as a predictor of brain injury in HIV infection.

Authors:  Ann B Ragin; Gypsyamber D'Souza; Sandra Reynolds; Eric Miller; Ned Sacktor; Ola A Selnes; Eileen Martin; Barbara R Visscher; James T Becker
Journal:  J Neurovirol       Date:  2011-09-29       Impact factor: 2.643

Review 2.  Platelets and Alzheimer's disease: Potential of APP as a biomarker.

Authors:  Geneviève Evin; Qiao-Xin Li
Journal:  World J Psychiatry       Date:  2012-12-22

3.  On the association analysis of genome-sequencing data: A spatial clustering approach for partitioning the entire genome into nonoverlapping windows.

Authors:  Heide Loehlein Fier; Dmitry Prokopenko; Julian Hecker; Michael H Cho; Edwin K Silverman; Scott T Weiss; Rudolph E Tanzi; Christoph Lange
Journal:  Genet Epidemiol       Date:  2017-03-20       Impact factor: 2.135

4.  Biomarkers of Alzheimer's disease among Mexican Americans.

Authors:  Sid E O'Bryant; Guanghua Xiao; Melissa Edwards; Michael Devous; Veer Bala Gupta; Ralph Martins; Fan Zhang; Robert Barber
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Multiple loci influencing hippocampal degeneration identified by genome scan.

Authors:  Scott A Melville; Jacqueline Buros; Antonio R Parrado; Badri Vardarajan; Mark W Logue; Li Shen; Shannon L Risacher; Sungeun Kim; Gyungah Jun; Charles DeCarli; Kathryn L Lunetta; Clinton T Baldwin; Andrew J Saykin; Lindsay A Farrer
Journal:  Ann Neurol       Date:  2012-06-28       Impact factor: 10.422

Review 6.  BACE1 as a potential biomarker for Alzheimer's disease.

Authors:  Boris Decourt; Marwan N Sabbagh
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  Distinctive RNA expression profiles in blood associated with Alzheimer disease after accounting for white matter hyperintensities.

Authors:  Zhouxian Bai; Boryana Stamova; Huichun Xu; Bradley P Ander; Jiajia Wang; Glen C Jickling; Xinhua Zhan; DaZhi Liu; Guangchun Han; Lee-Way Jin; Charles DeCarli; Hongxing Lei; Frank R Sharp
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jul-Sep       Impact factor: 2.703

Review 8.  Heart Failure and Cognitive Impairment: Clinical Relevance and Therapeutic Considerations.

Authors:  Tuoyo O Mene-Afejuku; Monica Pernia; Uzoma N Ibebuogu; Shobhana Chaudhari; Savi Mushiyev; Ferdinand Visco; Gerald Pekler
Journal:  Curr Cardiol Rev       Date:  2019

9.  Platelet biomarkers for a descending cognitive function: A proteomic approach.

Authors:  Haitao Yu; Yanchao Liu; Benrong He; Ting He; Chongyang Chen; Jiahua He; Xifei Yang; Jian-Zhi Wang
Journal:  Aging Cell       Date:  2021-05-04       Impact factor: 9.304

Review 10.  The Role of CLEC-2 and Its Ligands in Thromboinflammation.

Authors:  Danyang Meng; Man Luo; Beibei Liu
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.